287 related articles for article (PubMed ID: 34568095)
1. Can We Improve Antifungal Susceptibility Testing?
Durand C; Maubon D; Cornet M; Wang Y; Aldebert D; Garnaud C
Front Cell Infect Microbiol; 2021; 11():720609. PubMed ID: 34568095
[TBL] [Abstract][Full Text] [Related]
2. The future of fungal susceptibility testing.
Posteraro B; Sanguinetti M
Future Microbiol; 2014; 9(8):947-67. PubMed ID: 25302953
[TBL] [Abstract][Full Text] [Related]
3. Antifungal susceptibility testing in
Knabl L; Lass-Flörl C
Expert Rev Anti Infect Ther; 2020 Aug; 18(8):779-787. PubMed ID: 32324090
[TBL] [Abstract][Full Text] [Related]
4. New approaches for antifungal susceptibility testing.
Sanguinetti M; Posteraro B
Clin Microbiol Infect; 2017 Dec; 23(12):931-934. PubMed ID: 28377311
[TBL] [Abstract][Full Text] [Related]
5. Investigating Antifungal Susceptibility in
Delavy M; Dos Santos AR; Heiman CM; Coste AT
Front Cell Infect Microbiol; 2019; 9():19. PubMed ID: 30792970
[TBL] [Abstract][Full Text] [Related]
6. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
7. Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay.
Vatanshenassan M; Arastehfar A; Boekhout T; Berman J; Lass-Flörl C; Sparbier K; Kostrzewa M
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285227
[TBL] [Abstract][Full Text] [Related]
8. Antifungal Susceptibility Testing: Current Approaches.
Berkow EL; Lockhart SR; Ostrosky-Zeichner L
Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32349998
[TBL] [Abstract][Full Text] [Related]
9. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
10. The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro.
Cuenca-Estrella M; Rodriguez-Tudela JL
Expert Rev Anti Infect Ther; 2010 Mar; 8(3):267-76. PubMed ID: 20192681
[TBL] [Abstract][Full Text] [Related]
11. Rapid detection of fluconazole resistance in Candida tropicalis by MALDI-TOF MS.
Paul S; Singh P; A S S; Rudramurthy SM; Chakrabarti A; Ghosh AK
Med Mycol; 2018 Feb; 56(2):234-241. PubMed ID: 28992333
[TBL] [Abstract][Full Text] [Related]
12. The role of antifungal susceptibility testing in the therapy of candidiasis.
Hospenthal DR; Murray CK; Rinaldi MG
Diagn Microbiol Infect Dis; 2004 Mar; 48(3):153-60. PubMed ID: 15023422
[TBL] [Abstract][Full Text] [Related]
13. Rapid Antifungal Susceptibility Testing of Yeasts and Molds by MALDI-TOF MS: A Systematic Review and Meta-Analysis.
Knoll MA; Ulmer H; Lass-Flörl C
J Fungi (Basel); 2021 Jan; 7(1):. PubMed ID: 33477533
[TBL] [Abstract][Full Text] [Related]
14. Rapid identification and susceptibility testing of Candida spp. from positive blood cultures by combination of direct MALDI-TOF mass spectrometry and direct inoculation of Vitek 2.
Idelevich EA; Grunewald CM; Wüllenweber J; Becker K
PLoS One; 2014; 9(12):e114834. PubMed ID: 25489741
[TBL] [Abstract][Full Text] [Related]
15. Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.
Pontes L; Beraquet CAG; Arai T; Pigolli GL; Lyra L; Watanabe A; Moretti ML; Schreiber AZ
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871090
[TBL] [Abstract][Full Text] [Related]
16. Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata.
Vella A; De Carolis E; Mello E; Perlin DS; Sanglard D; Sanguinetti M; Posteraro B
Sci Rep; 2017 Aug; 7(1):9099. PubMed ID: 28831086
[TBL] [Abstract][Full Text] [Related]
17. Antifungal susceptibility testing: current role from the clinical laboratory perspective.
Posteraro B; Torelli R; De Carolis E; Posteraro P; Sanguinetti M
Mediterr J Hematol Infect Dis; 2014; 6(1):e2014030. PubMed ID: 24804003
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility-testing in Aspergillus species.
Lass-Flörl C; Perkhofer S
Mycoses; 2008 Sep; 51(5):437-46. PubMed ID: 18422914
[TBL] [Abstract][Full Text] [Related]
19. Paving the Way to Overcome Antifungal Drug Resistance: Current Practices and Novel Developments for Rapid and Reliable Antifungal Susceptibility Testing.
Heuer C; Bahnemann J; Scheper T; Segal E
Small Methods; 2021 Nov; 5(11):e2100713. PubMed ID: 34927979
[TBL] [Abstract][Full Text] [Related]
20. Detection of triazole resistance among Candida species by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS).
Saracli MA; Fothergill AW; Sutton DA; Wiederhold NP
Med Mycol; 2015 Sep; 53(7):736-42. PubMed ID: 26162474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
